Uploaded July 2012 | Updated September 2026, 1 week ago
Research funded by NIH at Massachusetts General Hospital has yielded a miniature, point-of-care Nuclear Magnetic Resonance (NMR) device that can non- invasively diagnose cancer and has demonstrated superior accuracy and speed when compared to standard biopsy. The micro-NMR does this by analyzing cells, proteins, nucleic acids, viruses, and bacteria from unpurified biological samples -- all in less than an hour. Using unprocessed samples eliminates the need for a lab and trained technicians.
For more information on the National Institute of Biomedical Imaging and Bioengineering at NIH go to nibib.nih.gov
Research funded by NIH at Massachusetts General Hospital has yielded a miniature, point-of-care Nuclear Magnetic Resonance (NMR) device that can non- invasively diagnose cancer and has demonstrated superior accuracy and speed when compared to standard biopsy. The micro-NMR does this by analyzing cells, proteins, nucleic acids, viruses, and bacteria from unpurified biological samples -- all in less than an hour. Using unprocessed samples eliminates the need for a lab and trained technicians.
For more information on the National Institute of Biomedical Imaging and Bioengineering at NIH go to nibib.nih.gov
